2024-11-19 14:31:35
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Anal Dysplasia Caused by HPV-16/18
Corporate/ 2023-07-23
INOVIO's VGX-3100 Demonstrates Posi...

PLYMOUTH MEETING,Pa.,Dec. 9,2020--INOVIO (NASDAQ:INO),a biotechnology company focused on bringing to market precisely designed DNA medicines...

Ascentage Pharma Announces Positive Data from Pivotal Phase II Studies of HQP1351 (Olverembatinib) in Patients with TKI-Resistant Chronic Myeloid Leukemia (CML) at 2020 American Society of Hematology (ASH) Annual Meeting
Corporate/ 2023-07-23
Ascentage Pharma Announces Positive Data...

SUZHOU,China,and ROCKVILLE,MD,Dec. 8,2020-- Ascentage Pharma (6855.HK),a globally focused,clinical-stage biotechnology company engaged in de...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release